Obesity and the risk for a hematological malignancy: Leukemia, lymphoma, or myeloma

Oncologist

Volumn 15, Issue 10, 2010, Pages 1083-1101

  Lichtman, Marshall A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Body mass index; Cancer; Leukemia; Lymphoma; Myeloma; Obesity

Indexed keywords

IDARUBICIN; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANTHROPOMETRY; ARTICLE; ATTRIBUTABLE RISK; B CELL LYMPHOMA; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DIFFERENTIATION SYNDROME; DISEASE ASSOCIATION; ETHNICITY; FOLLICULAR LYMPHOMA; GENDER; GENE FUNCTION; HEMATOPOIESIS; HIP CIRCUMFERENCE; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LEUKEMIA; LYMPHOMA; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOMA; NONHODGKIN LYMPHOMA; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; RACE DIFFERENCE; SIDE EFFECT; SMOKING; WAIST CIRCUMFERENCE;

CASE-CONTROL STUDIES; COHORT STUDIES; HUMANS; INCIDENCE; LEUKEMIA; LYMPHOMA; META-ANALYSIS AS TOPIC; MULTIPLE MYELOMA; OBESITY; RISK FACTORS;

EID: 77958566799     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0206     Document Type: Article

References (63)

1. Centers for Disease Control and Prevention. Overweight and Obesity. Available at http://www.cdc.gov/obesity/index.html, accessed June 25, 2010.
2. Flegal KM, Carroll MD, Ogden CL et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241.
3. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: New perspectives. Annu Rev Med 2010;61:301-316.
4. Wolin KY, Carson K, Colditz GA. Obesity and cancer. The Oncologist 2010;15:556-565.
5. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638.
6. Samanic C, Gridley G, Chow WH et al. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 2004;15: 35-43.
7. Pan SY, Johnson KC, Ugnat AM et al. Canadian Cancer Registries Epidemiology Research Group. Association of obesity and cancer risk in Canada. Am J Epidemiol 2004;159:259-268.
8. Reeves GK, Pirie K, Beral V et al. Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. BMJ 2007;335:1134-1144.
9. Oh SW, Yoon YS, Shin SA. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 2005;23:4742-4754.
10. Renehan AG, Tyson M, Egger M et al. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578.
11. Söderberg KC, Kaprio J, Verkasalo PK et al. Overweight, obesity and risk of haematological malignancies: A cohort study of Swedish and Finnish twins. Eur J Cancer 2009;45:1232-1238.
12. Renehan AG, Soerjomataram I, Tyson M et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 2010;126:692-702.
13. Młler H, Mellemgaard A, Lindvig K et al. Obesity and cancer risk: A Danish record-linkage study. Eur J Cancer 1994;30A:344-350.
14. Engeland A, Tretli S, Hansen S et al. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol 2007;165:44-52.
15. Fernberg P, Odenbro A, Bellocco R et al. Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: A nationwide cohort study in Sweden. Cancer Res 2007;67:5983-5986.
16. MacInnis RJ, English DR, Hopper JL et al. Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst 2005;97: 1154-1157.
17. Larsson SC, Wolk A. Overweight and obesity and incidence of leukemia:A meta-analysis of cohort studies. Int J Cancer 2008;122:1418-1421.
18. Kasim K, Levallois P, Abdous B et al. Lifestyle factors and the risk of adult leukemia in Canada. Cancer Causes Control 2005;16:489-500.
19. Ross JA, Parker E, Blair CK et al. Body mass index and risk of leukemia in older women. Cancer Epidemiol Biomarkers Prev 2004;13:1810-1813.
20. Estey E, Thall P, Kantarjian H et al. Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Leukemia 1997;11:1661-1664.
21. Wong O, Harris F, Yiying W et al. A hospital-based case-control study of acute myeloid leukemia in Shanghai: Analysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification. Regul Toxicol Pharmacol 2009;55:340-352.
22. Jeddi R, Ghédira H, Mnif S et al. High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia. Leuk Res 2010;34:545-547.
23. Konopleva M, Mikhail A, Estrov Z et al. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: Proliferative and anti-apoptotic activities. Blood 1999;93:1668-1676.
24. Considine RV, Caro JF. Leptin and the regulation of body weight. Int J Biochem Cell Biol 1997;29:1255-1272.
25. Gainsford T, Willson TA, Metcalf D et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 1996;93:14564-14568.
26. Strom SS, Yamamura Y, Kantarijian HM et al. Obesity, weight gain, and risk of chronic myeloid leukemia. Cancer Epidemiol Biomarkers Prev 2009;18:1501-1506.
27. Willett EV, Roman E. Obesity and the risk of Hodgkin lymphoma (United Kingdom). Cancer Causes Control 2006;17:1103-1106.
28. Paffenbarger RS Jr, Wing AL, Hyde RT. Characteristics in youth indicative of adult-onset Hodgkin's disease. J Natl Cancer Inst 1977;58:1489-1491.
29. Pan SY, Mao Y, Ugnat AM. Canadian Cancer Registries Epidemiology Research Group. Physical activity, obesity, energy intake, and the risk of non-Hodgkin's lymphoma: A population-based case-control study. Am J Epidemiol 2005;162:1162-1173.
30. Wolk A, Gridley G, Svensson M et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001;12:13-21.
31. Cerhan JR, Bernstein L, Severson RK et al. Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2005;16:1203-1214.
32. Chiu BC, Gapstur SM, Greenland P et al. Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2348-2354.
33. Chang ET, Hjalgrim H, Smedby KE et al. Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 2005;97:210-218.
34. Bosetti C, Dal Maso L, Negri E et al. Re: Body mass index and risk of malignant lymphoma in Scandinavian men and women [letter]. J Nat Cancer Inst 2005;97:860-861.
35. Dal Maso L, Talamini R, Montella M et al. Hepatitis B and C viruses and Hodgkin lymphoma: A case-control study from Northern and Southern Italy. Haematologica 2004;89:ELT17.
36. Chiu BC, Soni L, Gapstur SM et al. Obesity and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 2007;18:677-685.
37. Skibola CF. Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007;16:392-395.
38. Maskarinec G, Erber E, Gill J et al. Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: The multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2008;17:196-203.
39. Morton LM, Wang SS, Cozen W et al. Etiological heterogeneity among non-Hodgkin lymphoma subtypes. Blood 2008;112:5150-5160.
40. Willett EV, Morton LM, Hartge P et al. InterLymph Consortium. Non- Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph Consortium. Int J Cancer 2008;122:2062-2070.
41. Pylypchuk RD, Schouten LJ, Goldbohm RA et al. Body mass index, height, and risk of lymphatic malignancies: A prospective cohort study. Am J Epidemiol 2009;170:297-307.
42. Willett EV, Skibola CF, Adamson P et al. Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms. Br J Cancer 2005;93:811-816.
43. Larsson SC, Wolk A. Obesity and risk of non-Hodgkin's lymphoma: A meta-analysis. Int J Cancer 2007;121:1564-1570.
44. Troy JD, Hartge P, Weissfeld JL et al. Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol 2010;171:1270-1281.
45. Friedman GD, Herrinton LJ. Obesity and multiple myeloma. Cancer Causes Control 1994;5:479-483.
46. Khan MM, Mori M, Sakauchi F et al. JACC Study Group. Risk factors for multiple myeloma: Evidence from the Japan Collaborative Cohort (JACC) study. Asian Pac J Cancer Prev 2006;7:575-581.
47. Brown LM, Gridley G, Pottern LM et al. Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States. Cancer Causes Control 2001;12:117-125.
48. Blair CK, Cerhan JR, Folsom AR et al. Anthropometric characteristics and risk of multiple myeloma. Epidemiology 2005;16:691-694.
49. Cozen W, Gebregziabher M, Conti DV et al. Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma. Cancer Epidemiol Biomarkers Prev 2006;15:2285-2291.
50. Birmann BM, Giovannucci E, Rosner B et al. Body mass index, physical activity, and risk of multiple myeloma. Cancer Epidemiol Biomarkers Prev 2007;16:1474-1478.
51. Larsson SC, Wolk A. Body mass index and risk of multiple myeloma: A meta-analysis. Int J Cancer 2007;121:2512-2516.
52. Landgren O, Rajkumar SV, Pfeiffer RM et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood 2010;116:1056-1059.
53. Lichtman MA. Battling the hematological malignancies: The 200 years' war. The Oncologist 2008;13:126-138.
54. Lichtman MA. Cigarette smoking, cytogenetic abnormalities, and acute myelogenous leukemia. Leukemia 2007;21:1137-1140.
55. Lichtman MA, Vaughan JH, Hames CG. The distribution of serum immunoglobulins, anti-gamma-G globulins ("rheumatoid factors") and antinuclear antibodies in White and Negro subjects in Evans County, Georgia. Arthritis Rheum 1967;10:204-215.
56. Sjöström L, Gummesson A, Sjöström CD et al. Swedish Obese Subjects Study. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): A prospective, controlled intervention trial. Lancet Oncol 2009;10:653-662.
57. Wolin KY, Colditz GA. Can weight loss prevent cancer? Br J Cancer 2008; 99:995-999.
58. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004; 89:2583-2589.
59. Key TJ, Spencer EA, Reeves GK. Symposium 1. Overnutrition: Consequences and solutions. Obesity and cancer risk. Proc Nutr Soc 2010;69:86-90.
60. Hursting SD, Lashinger LM, Wheatley KW et al. Reducing the weight of cancer: Mechanistic targets for breaking the obesity-carcinogenesis link. Best Pract Res Clin Endocrinol Metab 2008;22:659-669.
61. Becker S, Dossus L, Kaaks R. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 2009;115: 86-96.
62. Dalamaga M, Karmaniolas K, Panagiotou A et al. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: A case-control study. Cancer Causes Control 2009;20:193-199.
63. Bray GA. The underlying basis for obesity: Relationship to cancer. J Nutr 2002;132(11 suppl):3451S-3455S.